v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue, net $ 607,000 $ 419,000 $ 1,366,000 $ 1,236,000
Cost of revenue 503,000 387,000 1,187,000 1,124,000
Gross profit 104,000 32,000 179,000 112,000
Operating Expenses:        
Research and development 1,240,000 1,429,000 3,278,000 4,195,000
Sales and marketing 835,000 694,000 2,043,000 2,119,000
General and administrative 1,014,000 588,000 2,512,000 1,860,000
Total operating expenses 3,089,000 2,711,000 7,833,000 8,174,000
Loss from operations (2,985,000) (2,679,000) (7,654,000) (8,062,000)
Interest expense (5,000) 0 (1,394,000) 0
Change in fair value of warrant liability 0 18,000 24,000 193,000
Change in fair value of derivative liability 0 0 0 (171,000)
Other expense, net 0 (47,000) (41,000) (50,000)
Loss before provision for income taxes (2,990,000) (2,708,000) (9,065,000) (8,090,000)
Provision for income taxes 0   3,000 7,000
Net loss (2,990,000) (2,708,000) (9,068,000) (8,097,000)
Convertible preferred stock dividend (20,000) (20,000) (60,000) (36,000)
Deemed dividend from warrant repricing 0   (134,000) 0
Net loss attributable to common stockholders $ (3,010,000) $ (2,728,000) $ (9,262,000) $ (8,133,000)
Net loss per common share - basic and diluted $ (0.39) $ (2.75) $ (2.15) $ (9.29)
Weighted average number of common shares used in computing net loss per common share 7,709,692 993,591 4,304,721 875,097

Source